Geara Abdallah Sassine, Castellanos Mario R, Bassil Claude, Schuller-Levis Georgia, Park Eunkue, Smith Marianne, Goldman Michael, Elsayegh Suzanne
Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.
Clin Dev Immunol. 2010;2010. doi: 10.1155/2010/418695. Epub 2010 Sep 16.
Parathyroid hormone (PTH) function as immunologic mediator has become interesting with the recent usage of PTH analogue (teriparatide) in the management of osteoporosis. Since the early 1980s, PTH receptors were found on most immunologic cells (neutrophils, B and T cells). The in vitro evaluations for a possible role of PTH as immunomodulator have shown inconsistent results mainly due to methodological heterogeneity of these studies: it used different PTH formulations (rat, bovine, and human), at different dosages and different incubating periods. In some of these studies, the lymphocytes were collected from uremic patients or animals, which renders the interpretation of the results problematic due to the effect of uremic toxins. Parathyroidectomy has been found to reverse the immunologic defect in patients with high PTH levels. Nonetheless, the clinical significance of these findings is unclear. Further studies are needed to define if PTH does have immunomodulatory effects.
随着甲状旁腺激素(PTH)类似物(特立帕肽)最近在骨质疏松症治疗中的应用,PTH作为免疫介质的功能已引起关注。自20世纪80年代初以来,在大多数免疫细胞(中性粒细胞、B细胞和T细胞)上发现了PTH受体。对PTH作为免疫调节剂可能作用的体外评估显示结果不一致,主要是由于这些研究方法的异质性:使用了不同的PTH制剂(大鼠、牛和人),不同剂量和不同孵育期。在其中一些研究中,淋巴细胞取自尿毒症患者或动物,由于尿毒症毒素的影响,这使得结果的解释存在问题。已发现甲状旁腺切除术可逆转PTH水平高的患者的免疫缺陷。然而,这些发现的临床意义尚不清楚。需要进一步研究来确定PTH是否确实具有免疫调节作用。